# Medical Oxygen Concentrators Market > 医用氧气浓缩器市场研究报告信息，按产品类型（便携式氧气浓缩器和固定式氧气浓缩器）、按技术（连续流量和脉冲剂量）、按适应症（慢性阻塞性肺病 (COPD)、哮喘、睡眠呼吸暂停等）、按最终用户（医院和诊所、家庭护理机构等）和按地区（北美、欧洲、亚太地区和世界其他地区）划分 - 预测至 2032 年 - **Forecast Period:** 2025 - 2035 - **CAGR:** 6.26% - **2024:** $ 3.59 Billion - **2025:** $ 3.82 Billion - **2035:** $ 7 Billion - **Key Players:** Companies such as Philips(NL), Invacare (US), AirSep (US), OxyGo (US), Drive DeVilbiss Healthcare (GB), Nidek Medical (JP), GCE Group (SE), Precision Medical (US), Caire Inc. (US) are some of the major participants in the global market. **Report ID:** MRFR/MED/6404-HCR · **Pages:** 90 · **Author:** Vikita Thakur & Kinjoll Dey · **Last Updated:** August 24, 2026 **URL:** https://www.marketresearchfuture.com/reports/medical-oxygen-concentrators-market-7876 --- ## Market Summary The Global Medical Oxygen Concentrators Market size was valued at USD 3.59 Billion in 2024, and the market is projected to grow from USD 3.815 Billion in 2025 to USD 7.003 Billion by 2035, registering a CAGR of 6.26% during the forecast period 2025–2035. North America led the market in 2024 with over 40% share, generating around USD 1.436 Billion in revenue.   Rising global prevalence of chronic respiratory diseases and increasing demand for home-based oxygen therapy are major growth drivers of the market. Expanding elderly population and improved healthcare accessibility are accelerating adoption of portable and efficient oxygen delivery systems worldwide.    According to the IHME (Global Burden of Disease Study), Chronic Obstructive Pulmonary Disease (COPD) affects approximately 392 million people globally, significantly increasing long-term oxygen therapy demand and supporting sustained growth in the medical oxygen concentrator market. ## Market Drivers ### Aging Population 人口老龄化的转变正在显着影响医用制氧机市场。老年人更容易患慢性呼吸道疾病，需要使用氧疗。随着65岁及以上人口比例持续增长，医用制氧机的需求预计将相应增加。   老年人往往更喜欢家庭医疗保健解决方案，这一事实加剧了这种人口趋势，这进一步推动了市场的发展。最近的预测表明，到 2030 年，老年人数量将超过 10 亿，这为制氧机制造商创造了巨大的市场机会。   - 根据世界银行卫生支出数据，印度等国家的医疗支出仍占GDP的3%至4%左右，明显低于超过9%的全球平均水平。这种成本优势吸引了医疗旅游业，增加了新兴医疗市场对制氧机等负担得起的呼吸护理解决方案的需求。 ### Rising Awareness of Home Healthcare Solutions 人们对家庭医疗保健解决方案的认识和接受度不断提高，这对医用制氧机市场产生了积极影响。患者和护理人员越来越认识到在舒适的家中接受医疗护理的好处，特别是对于需要长期氧疗的慢性病。   这一转变得到了医疗保健政策的支持，这些政策提倡家庭护理作为住院治疗的一种经济有效的替代方案。因此，家用制氧机的需求不断增加，市场估计未来五年销量可能增长 20%。这一趋势强调了制氧机在提高患者生活质量方面的重要性。   - 根据世界卫生组织 (WHO) 的数据，超过 50% 的慢性病医疗保健服务越来越多地在家庭中提供，而通过家庭护理可将医疗成本降低高达 30%，从而增加了全球对制氧机的需求。 ### Increasing Prevalence of Respiratory Disorders 慢性阻塞性肺病（COPD）和哮喘等呼吸系统疾病的发病率不断上升，是医用制氧机市场的主要驱动力。根据卫生统计数据，呼吸系统疾病是全世界发病和死亡的主要原因之一。这一趋势可能会增加对氧疗的需求，从而推动医用制氧机市场的发展。   随着医疗保健系统越来越认识到有效管理这些病症的必要性，氧气浓缩器的采用预计会增加。预计未来几年该市场的复合年增长率 (CAGR) 约为 10%，反映出对家庭氧疗解决方案日益增长的需求。   - 健康指标与评估研究所 (IHME) 报告称，全球有超过 4.54 亿例慢性呼吸道疾病，而每年有超过 300 万人死于慢性阻塞性肺病，这极大地推动了全球对氧疗设备和浓缩器的需求。 ### Supportive Government Policies and Regulations 支持性的政府政策和法规在塑造医用制氧机市场方面发挥着至关重要的作用。许多国家正在实施促进获得医用氧疗的政策，包括对患者的补贴和报销计划。这些举措旨在改善医疗保健结果并确保患者能够获得必要的医疗设备。   此外，监管机构正在制定制氧机的制造和分销标准，以提高产品的安全性和功效。因此，市场可能会稳定增长，批准的设备数量预计会增加，消费者信任度也会相应提高。   - 据泛美卫生组织 (PAHO) 称，美洲超过 35 个国家正在加强基本医疗设备的获取，同时国家医疗保健计划正在将覆盖范围扩大到数百万人，支持更多地采用制氧机进行呼吸护理。 ### Technological Innovations in Oxygen Concentrators 医用制氧机设计和功能的技术进步正在推动医用制氧机市场的发展。便携式和轻型模型、增强的氧气输送系统和用户友好的界面等创新使这些设备更容易使用并吸引消费者。   智能技术的集成，包括用于监测氧气水平的移动应用程序，也越来越受到关注。这些进步不仅提高了患者的依从性，还扩大了潜在的用户群。市场分析师表示，下一代制氧机的推出可能会导致未来几年市场扩张超过 15%，因为它们可以满足患者不断变化的需求。   - 无国界医生组织 (MSF) 表示，医用氧气项目在 70 多个国家开展，而氧气输送系统的创新改善了数百万患者的治疗可及性，支持广泛采用先进的便携式浓缩器技术。 ## Future Outlook The Medical Oxygen Concentrators Market size is projected to reach USD 7.003 billion by 2035, growing at a CAGR of 6.26%, driven by increasing respiratory diseases, technological advancements, and rising healthcare expenditures. **New opportunities:** - Expansion into telehealth integration for remote monitoring solutions. Development of portable oxygen concentrators for home healthcare markets. Partnerships with hospitals for bulk procurement and service contracts. By 2035, the market is expected to be robust, reflecting substantial growth and innovation. ## Segment Insights ### 按类型：便携式制氧机（最大）与固定式制氧机（增长最快） 该细分市场主要分为便携式和固定式制氧机。[便携式制氧机](https://www.marketresearchfuture.com/reports/portable-oxygen-concentrator-market-43273)由于其灵活性和易用性，可满足在接受氧疗时需要活动的患者的需求，因此占据最大的医用制氧机市场份额（63%）。另一方面，固定式制氧机越来越受欢迎，特别是那些喜欢更坚固的家用设备的人，从而占据了显着的市场份额。 曼谷医院扩大了其家庭护理呼吸支持计划，其中超过 60% 的出院呼吸系统患者被推荐使用便携式制氧机来支持活动和恢复，这与便携式制氧设备在现代呼吸治疗途径中的强大主导地位保持一致。 ### 按技术：连续流量（最大）与脉冲剂量（增长最快） 市场呈现出多样化的格局，连续流和脉冲剂量技术表现出不同的份额动态。由于其可靠性和效率，连续流设备目前占据最大的医用制氧机市场份额（66%），并且在有持续呼吸需求的患者中特别受欢迎。相比之下，脉冲剂量浓缩器因其创新的输送机制而受到关注，引起了在特定活动期间需要氧疗的患者的浓厚兴趣。用户偏好的这种多样化反映了人们对氧疗不同消耗模式的认识不断增强。 莱佛士医疗集团报告称，长期氧疗计划中超过 65% 的慢性呼吸道患者依赖连续流系统，这反映了其在医院和家庭护理环境中的临床稳定性和持续供氧优势。 ### 按适应症：慢性阻塞性肺疾病 (COPD)（最大）与睡眠呼吸暂停（增长最快） 医用制氧机市场适应症多种多样，其中慢性阻塞性肺疾病（COPD）所占份额最大，达 61%。该细分市场明显掩盖了其他细分市场，例如哮喘和睡眠呼吸暂停，凸显了与慢性阻塞性肺病治疗相关的关键需求。这种疾病带来的挑战确保了对制氧机的稳定需求，使其成为市场的基石。此外，归类为“其他”的条件对该份额的贡献很小，表明更利基的兴趣。 Asklepios Kliniken 管理着庞大的慢性阻塞性肺病 (COPD) 患者群体，其中慢性阻塞性肺病 (COPD) 占呼吸护理病房氧疗处方的近 60%，这凸显了其作为推动制氧机需求的主要适应症的主导地位。 ### 按最终用户：医院和诊所（最大）与家庭护理机构（增长最快） 最终用户的分布表明，医院和诊所拥有最大的医用制氧机市场份额，占 58%，这反映了它们在为呼吸困难患者提供即时护理方面的重要作用。他们对医院制氧机有着稳定的需求，因为它们可以满足急性和慢性疾病的需要，促进多种疾病的治疗。相比之下，家庭护理设置虽然规模较小，但由于人们对家庭治疗选择的偏好不断提高，以及技术进步使这些设备更加用户友好和有效，因此正在迅速获得关注。市场的增长趋势显示出向家庭护理环境的重大转变，由于人口老龄化以及人们对需要长期氧疗的呼吸系统疾病的认识不断增强，家庭护理环境变得越来越受欢迎。该行业受到技术创新的推动，这些创新增强了移动性和可用性，使患者在日常生活中拥有更大的独立性。对远程监控和个性化医疗保健解决方案的偏好也促进了家庭护理中制氧机需求的增加，使该细分市场成为市场中增长最快的领域。 曼谷医院报告称，由于急性呼吸护理需求和临床环境中的持续患者监测，制氧机的使用率大约 55-60% 发生在医院和诊所环境中。 ## Regional Market Share Analysis ### 北美：医疗保健创新领导者 北美在医用制氧机市场规模方面处于领先地位，到 2024 年将占全球收入的 40% 以上。该地区的增长是由人口老龄化、呼吸系统疾病患病率增加以及技术进步推动的。 FDA 等机构的监管支持也促进了市场扩张，确保医疗器械的安全性和有效性。美国是这个市场的主导者，其次是加拿大。 - 根据 CDC 数据，超过 1600 万美国人被诊断患有慢性阻塞性肺病，这极大地增加了氧疗需求。此外，GE 医疗集团报告称，美国医院广泛采用先进的呼吸护理系统，通过重症监护环境中的集成氧气输送和监测技术来支持改善患者的治疗效果。 Invacare、AirSep 和 OxyGo 等主要制氧机制造商在竞争格局中处于领先地位，专注于创新产品开发和战略合作伙伴关系，从而鼓励消费者购买制氧机。成熟的医疗基础设施进一步促进了市场增长，使北美成为医用氧气解决方案的中心。 ### 欧洲：新兴市场动态 2024年欧洲医用制氧机市场规模为10.8亿美元，成为第二大区域市场，占有30%的份额。慢性呼吸道疾病发病率的增加和支持性监管框架是关键驱动因素。欧洲药品管理局 (EMA) 实施了促进创新医疗器械审批、提高市场准入的指南。 - EMA 促进了多种先进呼吸医疗设备的批准，并通过监管途径支持氧气浓缩器更快地进入市场。这有助于提高整个欧洲的采用率，由于人口老龄化和环境健康挑战，慢性呼吸道疾病管理持续增加。 该地区的主要国家包括德国、法国和英国，飞利浦和 Drive DeVilbiss Healthcare 等便携式制氧机供应商在这些国家很突出。竞争格局的特点是既有成熟企业，也有新兴初创企业，重点关注技术进步和以患者为中心的解决方案。这种充满活力的环境预计将促进进一步的创新和市场渗透。 ### 亚太地区：快速增长的医疗保健行业 亚太地区正在成为医用制氧机市场的重要参与者，占据全球市场份额的 25% 左右。该地区的增长得益于医疗保健支出的增加、呼吸系统健康意识的提高以及老年人口的增加。旨在改善医疗保健基础设施的政府举措也有助于市场扩张。 由于庞大的患者群体，中国占据了 36% 的份额，价值 3.2 亿美元；而日本则由于技术进步和人口老龄化，占据了 24% 的份额，价值 2.1 亿美元。 日本、中国和印度等国家处于领先地位，其竞争格局以 Nidek Medical 和 GCE Group 等主要参与者为代表。该市场的特点是本地和国际公司混合，重点关注医用氧气解决方案的可负担性和可及性。随着医疗保健系统的不断发展和扩展，该地区有望实现大幅增长。 ### 中东和非洲：尚未开发的市场潜力 中东和非洲地区在医用制氧机市场逐渐崛起，目前占据全球约5%的份额。这一增长是由于人们对呼吸健康问题的认识不断提高以及对改善医疗服务的需求而推动的。旨在提高医疗保健可及性的政府举措也在市场发展中发挥着至关重要的作用。 沙特阿拉伯在医疗保健投资的推动下持有 37% 的份额，价值 0.7 亿美元，而南非在改善呼吸护理基础设施的支持下持有 26% 的份额，价值 0.5 亿美元。 南非和阿联酋等国家处于领先地位，其竞争格局包括本地和国际参与者。公司正致力于扩大其分销网络并提高产品可用性。随着医疗基础设施的改善，该地区对医用制氧机的需求预计将大幅增长。 ## Competitive Benchmarking The Medical Oxygen Concentrators Market is currently characterized by a dynamic competitive landscape, driven by increasing demand for home healthcare solutions and advancements in technology. Key players such as Philips (NL), Invacare (US), and AirSep (US) are strategically positioning themselves through innovation and regional expansion.    Philips (NL) focuses on enhancing product efficiency and user experience, while Invacare (US) emphasizes a broad product portfolio catering to diverse patient needs. AirSep (US), one of the key portable oxygen manufacturers, is leveraging its expertise in portable oxygen solutions, which aligns with the growing trend towards mobility in healthcare. Collectively, these strategies contribute to a moderately fragmented market, where competition is intensifying as companies seek to differentiate themselves through technological advancements and customer-centric solutions.   In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and enhance supply chain efficiency. This approach not only mitigates risks associated with The market demands. The competitive structure of the market appears to be moderately fragmented, with several key players exerting influence. The collective actions of these companies indicate a shift towards more integrated supply chains and localized production, which may enhance their competitive positioning.   In August 2025, Philips (NL) announced the launch of its latest oxygen concentrator model, which incorporates advanced AI technology to optimize oxygen delivery based on real-time patient data. This strategic move underscores Philips' commitment to innovation and positions the company to meet the evolving needs of patients requiring oxygen therapy. The integration of AI not only enhances patient outcomes but also sets a new standard for product functionality in the market.   In September 2025, Invacare (US) expanded its distribution network in Asia-Pacific, aiming to tap into the growing demand for home healthcare solutions in emerging markets. This strategic expansion is likely to bolster Invacare's market presence and facilitate access to a broader customer base. By localizing its operations, Invacare can better cater to regional preferences and regulatory requirements, thereby enhancing its competitive edge.   In July 2025, AirSep (US) entered into a strategic partnership with a leading telehealth provider to integrate remote monitoring capabilities into its oxygen concentrators. This collaboration is indicative of a broader trend towards digital health solutions, allowing for continuous patient monitoring and timely interventions. Such partnerships not only enhance product offerings but also align with the increasing emphasis on patient-centered care in the healthcare landscape.   As of October 2025, the competitive trends in the Medical Oxygen Concentrators Market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are playing a pivotal role in shaping the current landscape, enabling companies to leverage complementary strengths and enhance their market offerings.    Looking ahead, it is anticipated that competitive differentiation will evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability, as companies strive to meet the complex needs of patients and healthcare providers. .webp ## Recent News & Developments - Q2 2024: Inogen Launches Next-Generation Portable Oxygen Concentrator, the Inogen One G7 Inogen announced the commercial launch of its Inogen One G7 portable oxygen concentrator, featuring enhanced battery life and connectivity for remote patient monitoring, targeting both homecare and ambulatory use. This development is expected to drive the portable oxygen kit market growth. - Q2 2024: Philips Receives FDA 510(k) Clearance for SimplyGo Mini Portable Oxygen Concentrator Upgrade Philips announced it has received FDA 510(k) clearance for an upgraded version of its SimplyGo Mini portable oxygen concentrator, which includes improved battery performance and a lighter design for increased patient mobility. This development is expected to fuel the portable oxygen kit market growth. - Q3 2024: Invacare Appoints New CEO to Drive Growth in Respiratory Product Segment Invacare Corporation announced the appointment of a new Chief Executive Officer, with a strategic focus on expanding its respiratory and oxygen concentrator business in North America and Europe. - Q2 2024: ResMed Acquires OxyMed for $120 Million to Expand Oxygen Therapy Portfolio ResMed completed the acquisition of OxyMed, an Australian manufacturer of medical oxygen concentrators, to strengthen its global respiratory care offerings and accelerate innovation in portable oxygen solutions, driving the portable oxygen kit market growth. - Q1 2025: Teijin Opens New Medical Oxygen Concentrator Manufacturing Facility in Vietnam Teijin Limited inaugurated a new manufacturing facility in Vietnam dedicated to producing medical oxygen concentrators, aiming to meet rising demand in Southeast Asia and improve supply chain resilience. - Q2 2025: Chart Industries Secures Multi-Year Supply Contract with NHS for Oxygen Concentrators Chart Industries announced it has signed a multi-year contract to supply medical oxygen concentrators to the UK National Health Service (NHS), supporting hospital and homecare respiratory therapy programs. - Q3 2024: Nidek Medical India Launches Ultra-Portable Oxygen Concentrator for Indian Market Nidek Medical India introduced a new ultra-portable oxygen concentrator designed for the Indian market, featuring advanced filtration and energy-efficient operation for use in both urban and rural settings. - Q2 2024: Drive DeVilbiss Healthcare Announces Strategic Partnership with Medtronic for Oxygen Therapy Distribution Drive DeVilbiss Healthcare entered into a strategic partnership with Medtronic to distribute its line of medical oxygen concentrators across select European markets, expanding access to home-based respiratory care. - Q1 2025: Precision Medical Receives CE Mark for New High-Flow Oxygen Concentrator Precision Medical Inc. announced it has received CE Mark approval for its new high-flow oxygen concentrator, enabling commercial sales across the European Union and supporting critical care applications. - Q2 2025: O2 Concepts Raises $40 Million in Series C Funding to Accelerate Portable Oxygen Device Innovation O2 Concepts closed a $40 million Series C funding round to expand R&D and scale production of its next-generation portable oxygen concentrators, with a focus on smart, connected devices for homecare, thereby driving the portable oxygen concentrators market growth. - Q3 2024: Zhengzhou Olive Electronic Technology Wins Major Tender to Supply Oxygen Concentrators to Indonesian Hospitals Zhengzhou Olive Electronic Technology secured a government tender to supply thousands of medical oxygen concentrators to hospitals across Indonesia, supporting national healthcare infrastructure upgrades. - Q1 2025: Philips Launches Remote Monitoring Platform for Oxygen Concentrator Patients Philips introduced a new digital platform enabling remote monitoring and management of patients using its medical oxygen concentrators, aiming to improve outcomes and reduce hospital readmissions. ## Report Scope | MARKET SIZE 2024 | 3.59(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 3.815(USD Billion) | | MARKET SIZE 2035 | 7.003(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.26% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Philips (NL), Invacare (US), AirSep (US), OxyGo (US), Drive DeVilbiss Healthcare (GB), Nidek Medical (JP), GCE Group (SE), Precision Medical (US), Caire Inc. (US) | | Segments Covered | Product Type, Technology, Indication, End Users, Region | | Key Market Opportunities | Integration of advanced technologies enhances efficiency and accessibility in the market. | | Key Market Dynamics | Rising demand for home healthcare solutions drives innovation and competition in the market. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the projected market valuation of the Medical Oxygen Concentrators Market by 2035?** A: The projected market valuation for the Medical Oxygen Concentrators Market is 7.003 USD Billion by 2035. **Q: What was the market valuation of Medical Oxygen Concentrators in 2024?** A: The overall market valuation for Medical Oxygen Concentrators was 3.59 USD Billion in 2024. **Q: What is the expected CAGR for the Medical Oxygen Concentrators Market from 2025 to 2035?** A: The expected CAGR for the Medical Oxygen Concentrators Market during the forecast period 2025 - 2035 is 6.26%. **Q: Which segment of Medical Oxygen Concentrators had the highest valuation in 2024?** A: In 2024, the segment of Stationary Oxygen Concentrators had the highest valuation at 2.09 USD Billion. **Q: What are the key players in the market?** A: Key players in the market include Philips, Invacare, AirSep, OxyGo, and Drive DeVilbiss Healthcare. **Q: How much is the Portable Oxygen Concentrators segment projected to grow by 2035?** A: The Portable Oxygen Concentrators segment is projected to grow from 1.5 USD Billion in 2024 to 3.0 USD Billion by 2035. **Q: What is the market valuation for Continuous Flow technology in 2024?** A: The market valuation for Continuous Flow technology in 2024 was 2.15 USD Billion. **Q: Which end-user segment is expected to see significant growth by 2035?** A: The Hospitals and Clinics end-user segment is expected to grow from 1.5 USD Billion in 2024 to 3.0 USD Billion by 2035. **Q: What is the projected valuation for the Asthma indication segment by 2035?** A: The Asthma indication segment is projected to reach 1.5 USD Billion by 2035. **Q: How does the market for Pulse Dose technology compare to Continuous Flow technology in 2024?** A: In 2024, the market for Pulse Dose technology was valued at 1.44 USD Billion, compared to 2.15 USD Billion for Continuous Flow technology. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/medical-oxygen-concentrators-market-7876*